Nanjing Hicin Pharmaceutical Co Ltd (300584) — Long-term Investment Intensity

Latest as of September 2019: 15.7%

Nanjing Hicin Pharmaceutical Co Ltd (300584) has a Long-term Investment Intensity of 15.7% as of September 2019. Long-term investments of CN¥130.28 Million represent 15.7% of total assets of CN¥830.51 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Nanjing Hicin Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.

LT Investment Intensity

15.7%
LT Investments / Total Assets

Long-term Investments

CN¥130.28 Million
CNY

Total Assets

CN¥830.51 Million
CNY

Country

China
SHE

Nanjing Hicin Pharmaceutical Co Ltd Long-term Investment Intensity (2017–2018)

This chart shows how Nanjing Hicin Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of September 2019, the intensity stands at 15.7%, reflecting long-term investments of CN¥130.28 Million against total assets of CN¥830.51 Million CNY. Also explore 300584 current and non-current assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Nanjing Hicin Pharmaceutical Co Ltd (2017–2018)

The table below presents the year-by-year Long-term Investment Intensity for Nanjing Hicin Pharmaceutical Co Ltd from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Nanjing Hicin Pharmaceutical Co Ltd market cap and net worth.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 16.4% CN¥130.28 Million CN¥794.19 Million ▲ +16.3 pp
2017 0.1% CN¥800.00K CN¥632.30 Million
pp = percentage points